Nancy L Wengenack
Overview
Explore the profile of Nancy L Wengenack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1619
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khodadadi R, McHugh J, Chesdachai S, Wengenack N, Bosch W, Seville M, et al.
J Bone Jt Infect
. 2024 Nov;
9(5):207-212.
PMID: 39539732
: is an uncommon pathogen that has been reported to infect musculoskeletal structures. However, studies are largely limited to case reports, and little is known regarding management and outcomes of...
2.
de Hoog S, Walsh T, Ahmed S, Alastruey-Izquierdo A, Arendrup M, Borman A, et al.
J Clin Microbiol
. 2024 Nov;
62(12):e0093724.
PMID: 39526838
Medically important pathogenic fungi invade vertebrate tissue and are considered primary when part of their nature life cycle is associated with an animal host and are usually able to infect...
3.
Crowley P, Vaillant J, Shirley J, Wengenack N, Jo Kasten M
J Clin Tuberc Other Mycobact Dis
. 2024 Nov;
37:100489.
PMID: 39525346
is a rapidly growing nontuberculous mycobacterium that is rarely isolated from clinical specimens and is frequently considered to be a contaminant. We conducted a retrospective review of mycobacterial cultures positive...
4.
McHugh J, Bayless D, Ranganath N, Stevens R, Kind D, Wengenack N, et al.
J Clin Microbiol
. 2024 Oct;
62(11):e0105724.
PMID: 39440933
Importance: Our study addresses a significant knowledge gap in the clinical management of this non- species. Our retrospective review includes comprehensive AST data for 112 isolates, which is the largest...
5.
Yetmar Z, Khodadadi R, Chesdachai S, McHugh J, Clement J, Challener D, et al.
Infection
. 2024 Jun;
53(1):83-94.
PMID: 38922564
Background: Nocardia often causes pulmonary infection among those with chronic pulmonary disease or immunocompromising conditions. Trimethoprim-sulfamethoxazole (TMP-SMX) is recommended as first-line treatment, though little data exists regarding outcomes of different...
6.
Caldwell A, Gabaldon T, Mixao V, Wengenack N, Westley B, Stevens R
Int J Infect Dis
. 2024 Apr;
143:107040.
PMID: 38580069
Fungemia is common in critically ill patient populations, and is associated with a high rate of mortality, especially when caused by nonalbicans Candida species. Herein, we describe a fatal case...
7.
Brown-Elliott B, Wallace Jr R, Wengenack N, Workman S, Cameron A, Bush G, et al.
J Clin Microbiol
. 2024 Apr;
62(5):e0041524.
PMID: 38572983
No abstract available.
8.
Yetmar Z, Khodadadi R, Chesdachai S, McHugh J, Challener D, Wengenack N, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae122.
PMID: 38560606
Background: tends to cause infection in immunocompromised patients or those with chronic pulmonary disease. is known to recur, prompting the practice of secondary prophylaxis in patients perceived at high risk....
9.
de Hoog S, Walsh T, Ahmed S, Alastruey-Izquierdo A, Alexander B, Arendrup M, et al.
J Clin Microbiol
. 2024 Mar;
62(4):e0162523.
PMID: 38441056
No abstract available.
10.
Wengenack N, Brown-Elliott B, Parrish N, Salfinger M, Turenne C, Wallace Jr R, et al.
J Clin Microbiol
. 2024 Feb;
62(3):e0153123.
PMID: 38393324
No abstract available.